Maximus Inc (MMS) Stock Price, Quote & News

Company Profile

Maximus, Inc. operates as a provider of government services worldwide. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Federal Services segment offers business process services, eligibility and enrollment, outreach, and other services for federal health and human services programs; clinical services; and technology solutions, including application development and modernization services, enterprise business solutions, advanced analytics and...

Industry: Specialty Business Services

Sector: Industrials

Phone: 703 251 8500

Website: www.maximus.com

Address:

1600 Tysons Boulevard, Suite 1400, McLean, United States

DonCorleone77 Sep. 30 at 8:08 PM

$MMS Maximus awarded $62M contract from Pennsylvania DHS

0 · Reply

evanmedeiros Sep. 30 at 4:51 PM

First time looking at this stock here on @InvestorsBusinessDaily MarketSurge. Nice breakout and relative strength today after consolidating high and tight. Don't own any, but I'm watching. More company info here: https://research.investors.com/stock-quotes/nasdaq-MMS-inc-MMS.htm?utm_source=Evan_Medeiros&utm_medium=stocktwits&utm_campaign=SOCIAL+INFLUENCER&utm_id=SCINFLUENCER&utm_content=leaderboard#performance%3Fsrc=A00616 $MMS #IBDPartner

0 · Reply

ZacksResearch Sep. 17 at 5:57 PM

$MMS up 17.5% YTD — is it time to double down? 🚀 ✅ Outperformed its industry’s 5% decline ✅ Zacks Rank #1 (Strong Buy) ✅ Impressive earnings surprises, averaging 29.3% Discover why MMS is a top pick now 👉 https://www.zacks.com/stock/news/2753032/heres-why-maximus-stock-is-a-great-pick-for-your-portfolio?cid=sm-stocktwits-2-2753032-body-12912&ADID=SYND_STOCKTWITS_TWEET_2_2753032_BODY_12912

0 · Reply

ZacksResearch Sep. 17 at 4:57 PM

$MMS up 17.5% YTD — and still a strong pick 📈✨ Earnings growth prospects, CMMC Level 2 certification, and steady dividends are keeping momentum alive. Full investment case here 👉 https://www.zacks.com/stock/news/2753032/heres-why-maximus-stock-is-a-great-pick-for-your-portfolio?cid=sm-stocktwits-2-2753032-teaser-12907&ADID=SYND_STOCKTWITS_TWEET_2_2753032_TEASER_12907

0 · Reply

DonCorleone77 Sep. 10 at 10:37 AM

$MMS Maximus expands share repurchase authorization to $400M

0 · Reply

smartkarma Aug. 30 at 6:01 AM

$MMS | Maximus: Will Innovation in Veteran Services Deliver Game-Changing Results? "Maximus reported strong results for its fiscal year 2025 third quarter. The company's performance was marked by a significant increase in adjusted..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/maximus-will-innovation-in-veteran-services-deliver-game-changing-results

0 · Reply

ZacksResearch Aug. 11 at 3:50 PM

$MMS crushed Q3 expectations — here's why it's surging 📈 Quarterly earnings of $2.16/share beat Zacks Consensus by 55.4%, and revenue topped the consensus by 4.5%, driving a 4% rally since release. Revenue guidance is up, with FY earnings now expected between $7.35-$7.55/share, well above previous forecasts. Discover the full story here 👉 https://www.zacks.com/stock/news/2697877/maximus-q3-earnings-beat-estimates-stock-rallies-4?cid=sm-stocktwits-2-2697877-body-7187&ADID=SYND_STOCKTWITS_TWEET_2_2697877_BODY_7187

0 · Reply

ZacksResearch Aug. 11 at 2:50 PM

$MMS pops 4% on Q3 beat 📈 Earnings topped estimates, giving the stock a solid post-report boost. See the full Q3 breakdown here 👉 https://www.zacks.com/stock/news/2697877/maximus-q3-earnings-beat-estimates-stock-rallies-4?cid=sm-stocktwits-2-2697877-teaser-7151&ADID=SYND_STOCKTWITS_TWEET_2_2697877_TEASER_7151

0 · Reply

Estimize Aug. 7 at 10:36 PM

$MMS reported 2.16 EPS and 1,348 revenue for Q3. http://www.estimize.com/intro/mms?chart=historical&metric_name=eps&utm_content=MMS&utm_med

0 · Reply

FloatFrenzy Aug. 6 at 1:50 PM

$MMS Healthcare IT testing $80 resistance after base breakout. MACD about to cross bullish on weekly chart. Measured move suggests $90 target if $80 clears.

0 · Reply

Massachusetts Health Connector Awards New State-Based Marketplace Contract to Maximus

Oct 9, 2025, 9:00 AM EDT - 16 days ago

Maximus Schedules Fiscal 2025 Fourth Quarter and Year End Conference Call

Oct 6, 2025, 6:30 AM EDT - 20 days ago

Maximus Declares Quarterly Cash Dividend of $0.30 per Share

Sep 30, 2025, 4:00 PM EDT - 25 days ago

Maximus Selected to Expand the Impact of Pennsylvania's Health Plan Enrollment Services

Sep 23, 2025, 8:05 AM EDT - 4 weeks ago

Maximus: A Stable Compounder Trading At Just 12x Earnings

Sep 10, 2025, 6:30 AM EDT - 6 weeks ago

Maximus Board Authorizes Expansion to Purchase Program of Maximus Common Stock

Aug 19, 2025, 8:30 AM EDT - 2 months ago

Maximus Achieves Cybersecurity Maturity Model Certification (CMMC) Level 2

Aug 8, 2025, 5:17 AM EDT - 2 months ago

Maximus, Inc. (MMS) Q3 2025 Earnings Call Transcript

Aug 7, 2025, 6:30 AM EDT - 2 months ago

Maximus Reports Fiscal Year 2025 Third Quarter Results

Jul 28, 2025, 9:00 AM EDT - 3 months ago

Maximus Awarded $77 Million Advanced Cybersecurity Services Contract to Support Critical Air Force Cyber Command and Control Systems

Jul 10, 2025, 9:00 AM EDT - 3 months ago

Maximus Schedules Fiscal 2025 Third Quarter Conference Call

Jun 9, 2025, 2:00 PM EDT - 4 months ago

Maximus Unveils Total Experience Management (TXM) Solution with New AWS Integrations to Help Agencies Deliver Services More Efficiently and Effectively

May 10, 2025, 9:46 AM EDT - 6 months ago

Maximus, Inc. (MMS) Q2 2025 Earnings Call Transcript

May 8, 2025, 6:30 AM EDT - 6 months ago

Maximus Reports Fiscal Year 2025 Second Quarter Results

Apr 10, 2025, 9:00 AM EDT - 7 months ago

Maximus Schedules Fiscal 2025 Second Quarter Conference Call

Feb 6, 2025, 1:02 PM EST - 9 months ago

Maximus, Inc. (MMS) Q1 2025 Earnings Call Transcript

Feb 6, 2025, 6:30 AM EST - 9 months ago

Maximus Reports Fiscal Year 2025 First Quarter Results

Jan 9, 2025, 9:00 AM EST - 10 months ago

Maximus Schedules Fiscal 2025 First Quarter Conference Call

Jan 6, 2025, 8:00 AM EST - 10 months ago

Maximus Wins Contracts to Continue Medical Disability Exam Services for Veterans

Jan 6, 2025, 6:30 AM EST - 10 months ago

Maximus Declares Quarterly Cash Dividend of $0.30 Per Share

Dec 10, 2024, 8:00 AM EST - 11 months ago

Maximus Completes Divestiture of Australia and South Korea in Outside the U.S. Segment

Dec 4, 2024, 10:00 AM EST - 11 months ago

Maximus Earns URAC Accreditation for Health Utilization Management in Clinical Reviews

Nov 21, 2024, 4:12 PM EST - 1 year ago

Maximus, Inc. (MMS) Q4 2024 Earnings Call Transcript

Nov 20, 2024, 4:05 PM EST - 1 year ago

Maximus Reports Fourth Quarter and Full Year Results for Fiscal Year 2024

Oct 17, 2024, 9:00 AM EDT - 1 year ago

Maximus Schedules Fiscal 2024 Fourth Quarter and Year End Conference Call

Sep 10, 2024, 5:42 AM EDT - 1 year ago

Maximus: An Undervalued Gem That Can Provide Double-Digit Returns

Aug 8, 2024, 3:30 PM EDT - 1 year ago

Maximus, Inc. (MMS) Q3 2024 Earnings Call Transcript

Aug 7, 2024, 4:15 PM EDT - 1 year ago

Maximus Reports Fiscal Year 2024 Third Quarter Results

Jul 2, 2024, 9:00 AM EDT - 1 year ago

Maximus Schedules Fiscal 2024 Third Quarter Conference Call

Jun 21, 2024, 12:00 PM EDT - 1 year ago

Maximus Named a Top Washington-Area Workplace by The Washington Post

Jun 7, 2024, 11:00 AM EDT - 1 year ago

Maximus Supports Provider Module Certification for Ohio Department of Medicaid

Jun 3, 2024, 11:00 AM EDT - 1 year ago

Maximus Foundation Announces Over $2 Million in Grants for Nonprofits Nationwide

May 9, 2024, 2:10 PM EDT - 1 year ago

Maximus, Inc. (MMS) Q2 2024 Earnings Call Transcript

May 8, 2024, 4:15 PM EDT - 1 year ago

Maximus Reports Fiscal Year 2024 Second Quarter Results

Apr 11, 2024, 9:00 AM EDT - 1 year ago

Maximus Schedules Fiscal 2024 Second Quarter Conference Call

Apr 10, 2024, 10:30 AM EDT - 1 year ago

Maximus Launches Total Experience Management (TXM) Solution to Transform the Customer Experience of Federal Agencies

Apr 3, 2024, 11:00 AM EDT - 1 year ago

Maximus Selected by Florida's Department of Financial Services to Assist Residents with Outstanding Claims with Insolvent Insurance Companies

Feb 8, 2024, 6:55 PM EST - 1 year ago

Maximus, Inc. (MMS) Q1 2024 Earnings Call Transcript

Feb 7, 2024, 4:05 PM EST - 1 year ago

Maximus Reports Fiscal Year 2024 First Quarter Results

Jan 8, 2024, 1:00 PM EST - 1 year ago

Maximus Schedules Fiscal 2024 First Quarter Conference Call

Nov 16, 2023, 5:14 PM EST - 2 years ago

Maximus, Inc. (MMS) Q4 2023 Earnings Call Transcript

Nov 15, 2023, 4:05 PM EST - 2 years ago

Maximus Reports Fourth Quarter and Full Year Results for Fiscal Year 2023

Oct 12, 2023, 9:00 AM EDT - 2 years ago

Maximus Schedules Fiscal 2023 Fourth Quarter and Year End Conference Call

Oct 10, 2023, 6:30 AM EDT - 2 years ago

Maximus Announces Quarterly Dividend Increase to $0.30 per Share

Aug 6, 2023, 12:25 AM EDT - 2 years ago

Maximus, Inc. (MMS) Q3 2023 Earnings Call Transcript

Aug 2, 2023, 4:30 PM EDT - 2 years ago

Maximus Reports Fiscal Year 2023 Third Quarter Results

Jul 11, 2023, 6:30 AM EDT - 2 years ago

Maximus Declares Quarterly Cash Dividend of $0.28 per Share

Jun 29, 2023, 9:00 AM EDT - 2 years ago

Maximus Schedules Fiscal 2023 Third Quarter Conference Call

May 6, 2023, 2:30 PM EDT - 2 years ago

Maximus, Inc. (MMS) Q2 2023 Earnings Call Transcript

May 3, 2023, 4:30 PM EDT - 2 years ago

Maximus Reports Fiscal Year 2023 Second Quarter Results

DonCorleone77 Sep. 30 at 8:08 PM

$MMS Maximus awarded $62M contract from Pennsylvania DHS

0 · Reply

evanmedeiros Sep. 30 at 4:51 PM

0 · Reply

ZacksResearch Sep. 17 at 5:57 PM

0 · Reply

ZacksResearch Sep. 17 at 4:57 PM

0 · Reply

DonCorleone77 Sep. 10 at 10:37 AM

$MMS Maximus expands share repurchase authorization to $400M

0 · Reply

smartkarma Aug. 30 at 6:01 AM

0 · Reply

ZacksResearch Aug. 11 at 3:50 PM

0 · Reply

ZacksResearch Aug. 11 at 2:50 PM

0 · Reply

Estimize Aug. 7 at 10:36 PM

$MMS reported 2.16 EPS and 1,348 revenue for Q3. http://www.estimize.com/intro/mms?chart=historical&metric_name=eps&utm_content=MMS&utm_med

0 · Reply

FloatFrenzy Aug. 6 at 1:50 PM

$MMS Healthcare IT testing $80 resistance after base breakout. MACD about to cross bullish on weekly chart. Measured move suggests $90 target if $80 clears.

0 · Reply

ScamDiscovery Jul. 10 at 10:29 PM

$MMS Oh, Nick Langton, you slimy bastard. What a sham PR.

0 · Reply

GoldenTradesCapital Jul. 9 at 9:41 AM

STOCK RECOMMENDATION: $MMS – GOVERNMENT TECH POWERHOUSE 🏛️ Maximus provides digital services for federal and state programs. Aging population = more contracts. Follow us for more steady compounders 🔱

0 · Reply

TalkMarkets Jul. 4 at 2:54 AM

Payroll Stocks To Watch As June's Jobs Report Comes In Strong $MMS $PAYX $PCTY $DAY https://talkmarkets.com/content/stocks--equities/payroll-stocks-to-watch-as-junes-jobs-report-comes-in-strong?post=507421

0 · Reply

WolverineTradinglllc Jul. 1 at 2:49 PM

$MMS Good opportunity to open a short position. https://www.medicaleconomics.com/view/biggest-health-care-fraud-crackdown-in-u-s-history-targets-14-6b-in-alleged-scams

0 · Reply

smartkarma Jun. 30 at 5:04 AM

$MMS | Maximus Inc: Emphasis on Operational & Financial Discipline To Stabilize Margins! "Maximus, as reported in their recent second quarter fiscal 2025 earnings, exhibited a mixed performance, reflecting both strengths and challenges..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/maximus-inc-emphasis-on-operational-financial-discipline-to-stabilize-margins

0 · Reply

TalkMarkets Jun. 7 at 3:11 AM

Stocks To Watch As May's Jobs Report Beats Economists' Expectations: PCTY, MMS $MMS $PCTY https://talkmarkets.com/content/stocks--equities/stocks-to-watch-as-mays-jobs-report-beats-economists-expectations-pcty-mms?post=501701

0 · Reply

swingingtech Jun. 7 at 1:57 AM

$PCTY $MMS https://wallstreetwaves.com/stocks-to-monitor-following-strong-may-jobs-report-pcty-mms/

0 · Reply

swingingtech Jun. 4 at 2:46 AM

$MMS https://wallstreetwaves.com/director-acquisition-mms-executive-acquires-82-shares/

0 · Reply

ZacksResearch May. 21 at 3:53 PM

Is $MMS a hidden gem in the market? 💎 With a Zacks Rank #2 (Buy) and a VGM Score of B, Maximus, Inc. is positioned for strong performance, boasting stable dividends, strategic acquisitions, and solid government partnerships. The Zacks Consensus Estimate for fiscal 2025 earnings is pegged at $6.23, representing a 2.5% increase over the past 60 days. See why MMS stands out as a compelling investment opportunity 👉 https://www.zacks.com/commentary/2475571/heres-why-you-should-add-maximus-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2475571-body&ADID=SYND_STOCKTWITS_TWEET_2_2475571_BODY

0 · Reply

ZacksResearch May. 9 at 3:54 PM

🚀 $MMS Q2 Earnings Beat — Is the growth trend here to stay? 📈 💰 EPS of $2.01 crushed estimates by 46.7% and up 28% YoY! 📊 Revenues hit $1.36 billion, exceeding expectations by 5.8%. 🔍 Guidance raised for FY 2025, with revenues now projected between $5.25B and $5.4B, above consensus. Dive into the results here 👉 https://www.zacks.com/stock/news/2466270/maximus-q2-earnings-revenues-beat-estimates-increase-yy?cid=sm-stocktwits-0-2466270-body&ADID=SYND_STOCKTWITS_TWEET_0_2466270_BODY

0 · Reply

d_risk May. 8 at 4:12 PM

$MMS - Maximus Inc. Common Stock - 10Q - Updated Risk Factors MMS flags new risk: potential adverse impacts from legislative shifts and government budget or spending changes. #RegulatoryRisk #PolicyChanges #PublicSector #LegislativeImpact #GovernmentBudget 🟢 Added 🟠 Removed https://d-risk.ai/MMS/10-Q/2025-05-08

0 · Reply

Runner_G Apr. 10 at 1:54 AM

$PSTV Unfortunate that the price has fallen down so far. That said, we should have things to continue to look forward to such as: Q1 earnings with CNside going commercial. Q3 there is the P1b LM single dose expansuon data. Q3 also should include final p1/2 data on rGBM and theres no reason they should not be granted FDA breakthrough therapy designation. Q3 PBC IND approval (2 years late!) Lastly in Q4 we can expect the p1 LM multidose data. On the downside... we have to survive our big quarterly cash burn until these catalysts can help us. And the proxy proposal will still need to be approved very soon. So the immediate future will likely be rocky but there is no reason market cap should fall into single $MMS again, imo. Keep your heads up and lets do our best to support the Plus team achieve their goal of making rare CNS cancers a long term liveable condition vs 4-8 month death sentence. Thats why were here.

0 · Reply

Market Cap	4.94B
Revenue (ttm)	5.31B
Net Income (ttm)	306.91M
EPS (ttm)	N/A
PE Ratio	12.11
Forward PE	12.41
Profit Margin	5.78%
Debt to Equity Ratio	0.93

Volume	447,600
Avg Vol	559,934
Day's Range	N/A - N/A
Shares Out	56.35M
Stochastic %K	79%
Beta	0.57
Analysts	Strong Sell
Price Target	$102.00